Status:
TERMINATED
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
Lead Sponsor:
Sequenom, Inc.
Collaborating Sponsors:
Friends Research Institute, Inc.
Conditions:
Down Syndrome
Edwards Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
This study will evaluate the clinical performance of massively parallel sequencing (MPS) using the MaterniT21 PLUS LDT in the detection of fetal aneuploidy in circulating cfDNA extracted from a matern...
Eligibility Criteria
Inclusion
- Subject was pregnant with a multiple gestation and received NIPT with the MaterniT21 PLUS LDT and a valid test result is available;
- Subject was 18 years of age or older at the time of NIPT;
- Subject provides signed and dated informed consent in English;
Exclusion
- Subjects' treating physician is not located in the United States.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02226315
Start Date
August 1 2014
End Date
September 1 2015
Last Update
September 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Presbyterian/St. Luke's Medical Center
Denver, Colorado, United States, 80218